These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27118123)

  • 1. Penalized estimation for competing risks regression with applications to high-dimensional covariates.
    Ambrogi F; Scheike TH
    Biostatistics; 2016 Oct; 17(4):708-21. PubMed ID: 27118123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boosting for high-dimensional time-to-event data with competing risks.
    Binder H; Allignol A; Schumacher M; Beyersmann J
    Bioinformatics; 2009 Apr; 25(7):890-6. PubMed ID: 19244389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regularized Weighted Nonparametric Likelihood Approach for High-Dimension Sparse Subdistribution Hazards Model for Competing Risk Data.
    Tapak L; Kosorok MR; Sadeghifar M; Hamidi O; Afshar S; Doosti H
    Comput Math Methods Med; 2021; 2021():5169052. PubMed ID: 34589136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deviance residuals-based sparse PLS and sparse kernel PLS regression for censored data.
    Bastien P; Bertrand F; Meyer N; Maumy-Bertrand M
    Bioinformatics; 2015 Feb; 31(3):397-404. PubMed ID: 25286920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative incidence in competing risks data and competing risks regression analysis.
    Kim HT
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):559-65. PubMed ID: 17255278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A joint frailty-copula model between tumour progression and death for meta-analysis.
    Emura T; Nakatochi M; Murotani K; Rondeau V
    Stat Methods Med Res; 2017 Dec; 26(6):2649-2666. PubMed ID: 26384516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penalized estimation for proportional hazards models with current status data.
    Lu M; Li CS
    Stat Med; 2017 Dec; 36(30):4893-4907. PubMed ID: 28872695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of variable selection methods for high-dimensional survival data with competing events.
    Gilhodes J; Zemmour C; Ajana S; Martinez A; Delord JP; Leconte E; Boher JM; Filleron T
    Comput Biol Med; 2017 Dec; 91():159-167. PubMed ID: 29078093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic prediction of cumulative incidence functions by direct binomial regression.
    Grand MK; de Witte TJM; Putter H
    Biom J; 2018 Jul; 60(4):734-747. PubMed ID: 29577376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penalized Cox regression analysis in the high-dimensional and low-sample size settings, with applications to microarray gene expression data.
    Gui J; Li H
    Bioinformatics; 2005 Jul; 21(13):3001-8. PubMed ID: 15814556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semiparametric accelerated failure time cure rate mixture models with competing risks.
    Choi S; Zhu L; Huang X
    Stat Med; 2018 Jan; 37(1):48-59. PubMed ID: 28983935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cumulative incidence regression for dynamic treatment regimens.
    Chen LW; Yavuz I; Cheng Y; Wahed AS
    Biostatistics; 2020 Apr; 21(2):e113-e130. PubMed ID: 30371745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction to the Analysis of Survival Data in the Presence of Competing Risks.
    Austin PC; Lee DS; Fine JP
    Circulation; 2016 Feb; 133(6):601-9. PubMed ID: 26858290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tutorial in biostatistics: competing risks and multi-state models.
    Putter H; Fiocco M; Geskus RB
    Stat Med; 2007 May; 26(11):2389-430. PubMed ID: 17031868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model selection in competing risks regression.
    Kuk D; Varadhan R
    Stat Med; 2013 Aug; 32(18):3077-88. PubMed ID: 23436643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competing risks analysis with missing cause-of-failure-penalized likelihood estimation of cause-specific Cox models.
    Lô SN; Ma J; Manuguerra M; Moreno-Betancur M; Scolyer RA; Thompson JF
    Stat Methods Med Res; 2022 May; 31(5):978-994. PubMed ID: 35037794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marginal false discovery rates for penalized regression models.
    Breheny PJ
    Biostatistics; 2019 Apr; 20(2):299-314. PubMed ID: 29420686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dimensional Cox models: the choice of penalty as part of the model building process.
    Benner A; Zucknick M; Hielscher T; Ittrich C; Mansmann U
    Biom J; 2010 Feb; 52(1):50-69. PubMed ID: 20166132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sparse relative risk regression models.
    Wit EC; Augugliaro L; Pazira H; González J; Abegaz F
    Biostatistics; 2020 Apr; 21(2):e131-e147. PubMed ID: 30380025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stagewise pseudo-value regression for time-varying effects on the cumulative incidence.
    Zöller D; Schmidtmann I; Weinmann A; Gerds TA; Binder H
    Stat Med; 2016 Mar; 35(7):1144-58. PubMed ID: 26510388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.